Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
Employees
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
Employees

ASND Key Statistics

Market cap
15.82B
Market cap15.82B
Price-Earnings ratio
27.64
Price-Earnings ratio27.64
Dividend yield
Dividend yield
Average volume
523.29K
Average volume523.29K
High today
$254.93
High today$254.93
Low today
$249.99
Low today$249.99
Open price
$251.52
Open price$251.52
Volume
13.06K
Volume13.06K
52 Week high
$282.15
52 Week high$282.15
52 Week low
$160.86
52 Week low$160.86

Stock Snapshot

As of today, Ascendis Pharma A/S(ASND) shares are valued at $254.67. The company's market cap stands at 15.82B, with a P/E ratio of 27.64.

As of 2026-07-23, Ascendis Pharma A/S(ASND) stock has fluctuated between $249.99 and $254.93. The current price stands at $254.67, placing the stock +1.9% above today's low and -0.1% off the high.

The Ascendis Pharma A/S(ASND)'s current trading volume is 13.06K, compared to an average daily volume of 523.29K.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $160.86 at its lowest and $282.15 at its peak.

During the past year, Ascendis Pharma A/S(ASND) stock moved between $160.86 at its lowest and $282.15 at its peak.

ASND News

TipRanks 1h
Ascendis Pharma price target raised to $275 from $256 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Ascendis Pharma (ASND) to $275 from $256 and keeps an Overweight rating on the shares. Q2 earnings should reinf...

Simply Wall St 2d
Ascendis Pharma Could Be 14% Below Fair Value As Growth Hopes Hold

Ascendis Pharma (NasdaqGS:ASND) has drawn investor attention after recent trading left the stock around $251.76, with short term moves mixed but positive over t...

Ascendis Pharma Could Be 14% Below Fair Value As Growth Hopes Hold

Analyst ratings

100%

of 20 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.